Clinical Trials Browser

Phase NA × Suspended × tocilizumab × Clear all

NCT04394182 2022-03-29

ULTRA-COVID

Phase NA Suspended

Cytokine Release Syndrome, Pneumonia, Viral, Respiratory Distress Syndrome